Literature DB >> 3743465

Methotrexate therapy in rheumatoid arthritis. Current status.

W S Wilke, A H Mackenzie.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1986        PMID： 3743465     DOI： 10.2165/00003495-198632020-00001

Source DB:  PubMed          Journal:  Drugs        ISSN： 0012-6667            Impact factor:   9.546


× No keyword cloud information.
  73 in total

1.  Therapeutic suppression of tissue reactivity. I. Comparison of the effects of cortisone and aminopterin.

Authors:  R GUBNER
Journal:  Am J Med Sci       Date:  1951-02       Impact factor: 2.378

2.  Reversal of methotrexate binding to dihydrofolate reductase by dihydrofolate. Studies with pure enzyme and computer modeling using network thermodynamics.

Authors:  J C White
Journal:  J Biol Chem       Date:  1979-11-10       Impact factor: 5.157

Review 3.  The effect of amethopterin on the immune response.

Authors:  E D Thomas; R Storb
Journal:  Ann N Y Acad Sci       Date:  1971-11-30       Impact factor: 5.691

4.  The metabolic fate of tritiated methotrexate. II. Absorption and excretion in man.

Authors:  E S Henderson; R H Adamson; V T Oliverio
Journal:  Cancer Res       Date:  1965-08       Impact factor: 12.701

5.  The anti-inflammatory effect of some immunosuppressive agents.

Authors:  J E Stevens; D A Willoughby
Journal:  J Pathol       Date:  1969-02       Impact factor: 7.996

6.  The effect of organic acids on renal clearance of methotrexate in man.

Authors:  D G Liegler; E S Henderson; M A Hahn; V T Oliverio
Journal:  Clin Pharmacol Ther       Date:  1969 Nov-Dec       Impact factor: 6.875

7.  The characteristics of the membrane transport of amethopterin and the naturally occurring folates.

Authors:  I D Goldman
Journal:  Ann N Y Acad Sci       Date:  1971-11-30       Impact factor: 5.691

8.  Hepatotoxicity of prolonged methotrexate therapy for rheumatoid arthritis.

Authors:  A H Mackenzie
Journal:  Cleve Clin Q       Date:  1985

9.  Methotrexate therapy in rheumatoid arthritis: 15 years experience.

Authors:  R T Hoffmeister
Journal:  Am J Med       Date:  1983-12-30       Impact factor: 4.965

10.  Methotrexate in Reiter's disease.

Authors:  E T Owen; M L Cohen
Journal:  Ann Rheum Dis       Date:  1979-02       Impact factor: 19.103
View more
  6 in total

Review 1.  Hepatotoxicity of methotrexate in rheumatic diseases.

Authors:  S Kevat; M Ahern; P Hall
Journal:  Med Toxicol Adverse Drug Exp       Date:  1988 May-Jun

2.  Methotrexate therapy in rheumatoid arthritis patients diminishes lectin-induced mononuclear cell proliferation.

Authors:  R J Hine; M P Everson; J M Hardin; S L Morgan; G S Alarcòn; J E Baggott; W J Koopman; C L Krumdieck
Journal:  Rheumatol Int       Date:  1990       Impact factor: 2.631

Review 3.  Pharmacokinetic considerations in the treatment of inflammatory bowel disease.

Authors:  M Schwab; U Klotz
Journal:  Clin Pharmacokinet       Date:  2001       Impact factor: 6.447

Review 4.  New perspectives of secondary and tertiary therapy for rheumatoid arthritis.

Authors:  R F Willkens
Journal:  Drugs       Date:  1989-05       Impact factor: 9.546

5.  Better effect of methotrexate on C-reactive protein during daily compared to weekly treatment in rheumatoid arthritis.

Authors:  P Seideman
Journal:  Clin Rheumatol       Date:  1993-06       Impact factor: 2.980

Review 6.  Methotrexate in rheumatoid arthritis. An update.

Authors:  B Bannwarth; L Labat; Y Moride; T Schaeverbeke
Journal:  Drugs       Date:  1994-01       Impact factor: 9.546
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.